share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11

Benzinga ·  Jun 8, 2023 05:20

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and raises the price target from $9 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment